A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed PD-L1 IHC low/unknown stage IV squamous cell lung cancers.

e21035Background: Therapeutic options for SQCLC pts are limited. The efficacy of platinum doublets, the standard first-line treatment for PD-L1 < 50% pts and pts who have progressed on first-line p...